International Flavors & Fragrances Inc. (IFF)
After hours:
| Previous close | 83.60 |
| Open | 83.56 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 1000 |
| Day's range | 83.45 - 84.26 |
| 52-week range | 62.11 - 97.49 |
| Volume | |
| Avg. volume | 2,251,014 |
| Market cap | 21.439B |
| Beta (5Y monthly) | 1.24 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.60 (1.91%) |
| Ex-dividend date | 21 Mar 2024 |
| 1y target est | N/A |
- Business Wire
IFF to Release First Quarter 2024 Results on May 6, 2024
NEW YORK, April 16, 2024--IFF (NYSE:IFF) today announced that it will release its first quarter 2024 earnings results following the market close on Monday, May 6, 2024. The management team will host a live webcast on Tuesday, May 7, 2024 at 9:00 a.m. ET to discuss results and outlook with the investor community.
- Business Wire
IFF Completes Divestiture of Cosmetics Ingredients Business
NEW YORK, April 03, 2024--IFF (NYSE: IFF) today announced that it has completed the previously announced divestiture of its Cosmetic Ingredients business to Clariant, a sustainably focused specialty chemicals company. As a part of Clariant, the business will continue to deliver innovative ingredients for the cosmetic and personal care product portfolio.
- PR Newswire
IFF Brings Science-Backed Excipients to Asia Pharmaceutical Industry at CPhI Japan 2024
IFF, a global leader in food and beverage, home and personal care and health, will present its broad portfolio and latest excipient technology to CPhI Japan 2024 at booth 5K21, Tokyo Big Sight, Tokyo from April 17-19.IFF's Pharma Solutions offers high-quality pharmaceutical solutions backed by extensive research and expertise. The team will showcase its comprehensive cellulosic-derived excipients portfolio of innovative solutions, from binders and disintegrants to lubricants and matrix systems a
